GlassScriptPhysician profile
Sarah N Hocker
NPI 1689068736
$4,783.27
in general payments reported to CMS, 2019-2025
21 companies · $444 in 2025
The $444 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,983 · 2020: $601 · 2021: $28.01 · 2022: $64.99 · 2023: $33.20 · 2024: $629 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.59 |
| Education | $208.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,103.91 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $636.74 | 2019 | |
| Lilly USA, LLC | $430.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $395.66 | 2019 | |
| Janssen Biotech, INC. | $387.33 | 2019-2025 | Tremfya, Simponi, Stelara |
| Janssen Scientific Affairs, LLC | $360.38 | 2019-2020 | |
| Genzyme Corporation | $337.60 | 2019-2025 | |
| Celgene Corporation | $304.86 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $185.82 | 2019 | |
| Genentech USA, INC. | $121.33 | 2019 | |
| Allergan, INC. | $97.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $75.90 | 2024 | Sotyktu |
| Incyte Corporation | $64.99 | 2022 | |
| Galderma Laboratories, L.P. | $51.61 | 2021-2025 | Nemluvio |
| Ucb, INC. | $50.53 | 2024-2025 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $49.82 | 2019-2024 | Adbry |
| Vyne Pharmaceuticals INC. | $43.61 | 2020 | |
| Amgen INC. | $31.39 | 2020 | |
| Biofrontera INC. | $22.31 | 2020 | |
| Arcutis Biotherapeutics, INC. | $18.35 | 2025 | Zoryve |
| Pfizer INC. | $13.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.